Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Director departure
Appointed director
Echo Therapeutics, Inc. (ECTE) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/15/2015 8-K Quarterly results
Docs: "Echo Therapeutics, Inc. Announces 2014 Financial Results"
08/19/2014 8-K Quarterly results
Docs: "Echo Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Provides Business Update 40%-50% Monthly Cash Burn Reduction Initiatives Implemented Increased Focus on Key Symphony CGM System Enhancements"
05/13/2014 8-K Quarterly results
Docs: "Company to Host Conference Call Today, May 9, 2014 at 9:00 AM EDT"
04/01/2014 8-K Quarterly results
Docs: "Echo Therapeutics, Inc. Announces 2013 Financial Results Company to Host Conference Call Today, March 27, 2014 at 9:00 AM ET"
08/09/2013 8-K Form 8-K - Current report
05/10/2013 8-K Form 8-K - Current report
03/22/2013 8-K Form 8-K - Current report
11/09/2012 8-K Form 8-K - Current report
08/14/2012 8-K Form 8-K - Current report
05/11/2012 8-K Form 8-K - Current report
03/19/2012 8-K Form 8-K - Current report
11/08/2011 8-K Form 8-K - Current report
08/16/2011 8-K Form 8-K - Current report
03/30/2007 8-K Form 8-K - Current report
11/20/2006 8-K Form 8-K - Current report
08/11/2006 8-K Quarterly results
Docs: "SONTRA MEDICAL CORPORATION Consolidated Balance Sheets As of, June 30, 2006 December 31, 2005 ASSETS Current Assets: Cash and cash equivalents $ 711,531 $ 1,016,792 Short term investments 2,300,000 3,000,000 Accounts receivable — 1,129 Inventory, net of reserve for obsolescence 44,509 31,250 Prepaid expenses and other current assets 71,840 65,468 Total current assets 3,127,880 4,114,639 Property and Equipment, at cost: Computer equipment 248,175 241,324 Office and laboratory equipment 593,576 593,576 Furniture and fixtures 14,288 14,288 Manufacturing equipment 522,796 224,888 Leasehold improvements 177,768 177,768 1,556,603 1,251,844 Less-Accumulated depreciation and amortization Net property and equipment 575,256 357,186 Other Assets: Restricted cash 19,949 29,248 Deposits and other asse..."
05/12/2006 8-K Quarterly results
Docs: "SONTRA MEDICAL CORPORATION Consolidated Statements of Loss Three Months Ended March 31, 2006 2005 Revenue: Product revenue $ 14,526 $ 116,053 Licensing revenue 12,501 - Total revenue 27,027 116,053 Cost of product revenue 30,513 80,154 Gross profit 35,899 Operating Expenses: Research and development 763,358 906,300 Selling, general and administrative 495,061 473,809 Total operating expenses 1,258,419 1,380,109 Loss from operations Interest income 39,318 53,030 Interest expense - Net loss Accretion of dividend on Series A Convertible Preferred Stock Net loss applicable to common shareholders $ $ Net loss per common share, basic and diluted $ $ Basic and diluted weighted average common shares outstanding 23,597,289 22,131,657 SONTRA MEDICAL CORPORATION Consolidated Balance Sheets As of, M..."
03/16/2006 8-K Quarterly results
Docs: "-PRESS RELEASE DATED MARCH 16, 2006"
11/15/2005 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports Third Quarter 2005 Results and Business Update"
08/10/2005 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports Second Quarter 2005 Results and Business Update"
05/11/2005 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports First Quarter 2005 Results and Business Update"
02/17/2005 8-K Quarterly results
Docs: "Sontra Medical Reports Fourth Quarter and Fiscal Year 2004 Results and Business Update"
11/12/2004 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports Third Quarter 2004 Financial Results and Product Update"
08/18/2004 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports Second Quarter 2004 Financial Results and Product Update"
05/11/2004 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports First Quarter 2004 Financial Results FRANKLIN, Mass., May 10 — Sontra Medical Corporation announced today financial results for the first quarter ended March 31, 2004. For the three months ended March 31, 2004, the net loss applicable to common stockholders was $1,403,000, or $.11 per share, as compared to $951,000, or $.10 per share, for the same period in 2003. The Company's cash balance increased from $4,869,000 at December 31, 2003 to $6,273,000 at March 31, 2004. On January 15, 2004, the Company received a $1.5 million payment from Bayer Health Care LLC's Diagnostic Division pursuant to a license agreement executed in July 2003 for Sontra's non-invasive glucose monitoring technology. Also during the first quarter, Sontra realized net proceeds of $1,0..."
03/18/2004 8-K Quarterly results
Docs: "As of December 31, 2003 2002"
11/13/2003 8-K Quarterly results
Docs: "Sontra Medical Corporation Reports Third Quarter Financial Results Records First Quarterly Net Income and Significantly Improves Balance Sheet FRANKLIN, Mass., Nov. 12 — Sontra Medical Corporation announced today financial results for the third quarter and nine months ended September 30, 2003. For the three months ended September 30, 2003, net income was $856,000 compared to a net loss of $1,064,000 in 2002. Net loss applicable to common shareholders for the three months ended September 30, 2003 was $1,351,000, or $.14 per share versus $1,064,000, or $.11 per share in 2002. In the third quarter of 2003, the Company recorded a $2,206,000 deemed dividend charge for a beneficial conversion discount and accretion of dividends on the Series A Convertible Preferred Stock. This non-cash charge to..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy